Your browser doesn't support javascript.
loading
A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine.
Jangra, Sonia; Landers, Jeffrey J; Rathnasinghe, Raveen; O'Konek, Jessica J; Janczak, Katarzyna W; Cascalho, Marilia; Kennedy, Andrew A; Tai, Andrew W; Baker, James R; Schotsaert, Michael; Wong, Pamela T.
Afiliação
  • Jangra S; Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, United States.
  • Landers JJ; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Rathnasinghe R; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.
  • O'Konek JJ; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Janczak KW; Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Cascalho M; Department of Microbiology, Icahn School of Medicine at Mount Sinai New York, NY, United States.
  • Kennedy AA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Tai AW; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Baker JR; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Schotsaert M; Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Wong PT; Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, MI, United States.
Front Immunol ; 12: 729189, 2021.
Article em En | MEDLINE | ID: mdl-34603303

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Sintéticas / Adjuvantes Imunológicos / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Sintéticas / Adjuvantes Imunológicos / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça